Results 241 to 250 of about 36,146 (282)
Some of the next articles are maybe not open access.
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Retina, 2005This review summarizes the data reported in peer-reviewed literature and presents current knowledge on differentiation, natural history, and therapeutic outcomes of neovascular age-related macular degeneration (AMD).The MEDLINE database was searched to review natural history of neovascular AMD and therapeutic effects of available treatments.The search ...
openaire +2 more sources
Innovative therapies for neovascular age-related macular degeneration
Expert Opinion on Pharmacotherapy, 2019Introduction: Investigational anti-VEGF treatments for neovascular age-related macular degeneration (nAMD) aim to improve visual outcomes and reduce treatment burden; these include long-acting agents, combination strategies, topical agents, sustained-release, and genetic therapies.
Hasenin, Al-Khersan +3 more
openaire +2 more sources
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Immunotherapy, 2013Neovascular age-related macular degeneration (AMD) is the leading cause of legal blindness in patients over the age of 50 in the western world. Intravitreally administered anti-VEGF drugs have been developed to halt neovascular growth in AMD. Randomized trials have demonstrated the excellent safety profile and significant benefit of anti-VEGF therapy ...
David, Xu, Peter K, Kaiser
openaire +2 more sources
Macular atrophy development in neovascular age-related macular degeneration
European Journal of Ophthalmology, 2020Dan Călugăru, Mihai Călugăru
openaire +2 more sources
Cancer treatment and survivorship statistics, 2022
Ca-A Cancer Journal for Clinicians, 2022Kimberly D Miller +2 more
exaly